A detailed history of Sumitomo Mitsui Ds Asset Management Company, LTD transactions in Repligen Corp stock. As of the latest transaction made, Sumitomo Mitsui Ds Asset Management Company, LTD holds 3,582 shares of RGEN stock, worth $489,695. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,582
Previous 3,587 0.14%
Holding current value
$489,695
Previous $659,000 31.56%
% of portfolio
0.01%
Previous 0.01%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 30, 2024

SELL
$120.0 - $182.95 $600 - $914
-5 Reduced 0.14%
3,582 $451,000
Q1 2024

May 02, 2024

SELL
$170.78 - $208.42 $4,098 - $5,002
-24 Reduced 0.66%
3,587 $659,000
Q3 2023

Oct 30, 2023

SELL
$138.78 - $176.51 $2,775 - $3,530
-20 Reduced 0.55%
3,611 $574,000
Q4 2022

Jan 26, 2023

BUY
$162.42 - $220.56 $589,747 - $800,853
3,631 New
3,631 $0

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.59B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Sumitomo Mitsui Ds Asset Management Company, LTD Portfolio

Follow Sumitomo Mitsui Ds Asset Management Company, LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sumitomo Mitsui Ds Asset Management Company, LTD, based on Form 13F filings with the SEC.

News

Stay updated on Sumitomo Mitsui Ds Asset Management Company, LTD with notifications on news.